-
Weight loss drugs don't increase risk of pancreatitis, adverse cardiac events in patients with high triglycerides: Study
In a major new study, researchers from Intermountain Health in Salt Lake City have found that weight loss drugs used... Read more -
Targeted vitamin D3 supplementation cuts risk of second heart attack in half, study finds
A tailored approach of vitamin D3 supplementation in patients who have suffered a heart attack significantly reduces their risk of... Read more -
Routine use of metabolic drug recommended for all kidney function levels
The results of two large-scale studies demonstrate that sodium-glucose co-transporter 2 (SGLT2) inhibitors significantly reduce the risk of kidney disease... Read more -
Sotagliflozin outperforms dapagliflozin for reducing salt- sensitive hypertension and kidney injury in rats
Sodium-glucose co-transporter 2 (SGLT2) inhibitors, initially developed to treat type 2 diabetes, have significant heart- and kidney- protective effects.... Read more -
AI model predicts drug toxicity using differences between animal models and humans
In the UK, there was a case where TGN1412, an immunotherapy under development, triggered a cytokine storm within hours of... Read more -
Trump unveils deals to lower costs of some weight-loss drugs
US President Donald Trump announced deals Thursday with pharmaceutical giants Eli Lilly and Novo Nordisk to lower the prices of... Read more -
Review finds no link between acetaminophen use in pregnancy and neurodevelopmental disorders
A rigorous systematic review of the present state of knowledge on the use of acetaminophen during pregnancy and the risk... Read more -
Could pain medication be causing your headaches?
It seems contradictory: the pills you're taking for headaches might actually be perpetuating them. Medication-overuse headache is a well-documented medical... Read more -
Real-world responses reveal which patients benefit most from new schizophrenia drug
Each year, about 100,000 Americans experience psychosis, a serious condition that disrupts thoughts and perceptions so profoundly that it can... Read more -
Study supports wider use of FDA-approved drug for rare muscle disease
UNC School of Medicine researchers have led an international clinical trial of patients with generalized myasthenia gravis, finding the therapy... Read more -
Common heartburn and blood pressure medicines linked to adverse breast cancer outcomes in large global study
A major international study involving 23,000 people has found concerning evidence about the impact of a range of common, everyday... Read more -
Existing drug could reduce breast cancer risk in pre-menopausal women
A University of Manchester study reveals a drug approved for use in other conditions could be repurposed as a preventive... Read more -
Tool unmasks deep psychological and societal factors for medication nonadherence
A pioneering patient-reported outcome tool, developed by health care company Observia with the support of Kingston University, has shown significant... Read more -
Common antibiotic may reduce schizophrenia risk, study suggests
A commonly prescribed antibiotic could help reduce the risk of some young people developing schizophrenia, new research published in the... Read more -
PFAS may be eliminated from the body faster with certain medicines, study suggests
Certain medicines can cause the environmental toxin PFAS to be eliminated from the body faster, according to a study from... Read more
